High Air Pollution Rates Found to Boost Breast Cancer Incidence

September 11, 2023 by Dan McCue
High Air Pollution Rates Found to Boost Breast Cancer Incidence
The Statue of Liberty is seen on June 7, 2022 through a haze-filled sky from the Staten Island Ferry in New York. The smoke from Canadian wildfires that drifted into the U.S. led to a spike in people with asthma visiting emergency rooms — particularly in the New York area. (Yuki Iwamura, Associated Press)

WASHINGTON — People living in areas with high levels of particulate air pollution are likely to experience an increased incidence of breast cancer, according to a new study conducted by National Institutes of Health researchers.

Their work, published in the Journal of the National Cancer Institute, is one of the largest studies to date looking at the relationship between outdoor air pollution, specifically fine particulate matter, and breast cancer incidence. 

The researchers saw that the largest increases in breast cancer incidence were among women who on average had higher particulate matter levels near their homes prior to enrolling in the study, compared to those who lived in areas with lower levels of particulates. 

The research was done by scientists at the National Institute of Environmental Health Sciences and the National Cancer Institute, and for the sake of their study, particulate matter was defined as a mixture of solid particles and liquid droplets found in the air.

The particulates come from a number of sources, including motor vehicle exhaust, combustion processes (e.g., oil, coal), wood smoke/vegetation burning, and industrial emissions.

The particulate matter pollution measured in this study was 2.5 microns in diameter or smaller, meaning the particles are small enough to be inhaled deep into the lungs. The Environmental Protection Agency has a website known as Air Now where residents can enter their zip code and get the air quality information, including PM2.5 levels, for their area.

“We observed an 8% increase in breast cancer incidence for living in areas with higher PM2.5 exposure. Although this is a relatively modest increase, these findings are significant given that air pollution is a ubiquitous exposure that impacts almost everyone,” said Alexandra White, Ph.D., lead author and head of the Environment and Cancer Epidemiology Group at NIEHS. “These findings add to a growing body of literature suggesting that air pollution is related to breast cancer.” 

The study was conducted using information from the NIH-AARP Diet and Health Study, which enrolled more than 500,000 men and women between 1995 and 1996 in six states (California, Florida, Pennsylvania, New Jersey, North Carolina and Louisiana) and in two metropolitan areas (Atlanta, Georgia, and Detroit, Michigan). The women in the cohort were on average about 62 years old and most identified as being non-Hispanic White. They were followed for approximately 20 years, during which 15,870 breast cancer cases were identified.

The researchers estimated annual average historical PM2.5 concentrations for each participant’s residence. They were particularly interested in air pollution exposures during a period of 10-15 years prior to enrollment in the study, given the length of time it takes for some cancers to develop. Most previous studies have assessed breast cancer risk in relation to air pollution around the time of study enrollment and did not consider past exposures.

“The ability to consider historic air pollution levels is an important strength of this research,” said Rena Jones, Ph.D., senior author and principal investigator of the study at NCI. “It can take many years for breast cancer to develop and, in the past, air pollution levels tended to be higher, which may make previous exposure levels particularly relevant for cancer development.”

To consider how the relationship between air pollution and breast cancer varied by the type of tumor, the researchers evaluated estrogen receptor-positive and -negative tumors separately. They found that PM2.5 was associated with a higher incidence of ER+ breast cancer, but not ER- tumors. This suggests that PM2.5 may affect breast cancer through an underlying biologic pathway of endocrine disruption. ER+ tumors are the most common tumors diagnosed among women in the United States.

The authors note that the study was limited in its ability to explore any differences in the relationship between air pollution and breast cancer across the different study areas. They suggest future work should explore how the regional differences in air pollution, including the various types of PM2.5 pollution that women are exposed to, could impact a woman’s risk of developing breast cancer.

Dan can be reached at [email protected] and at https://twitter.com/DanMcCue

 

A+
a-
  • air pollution
  • breast cancer
  • National Institutes of Health
  • particulates
  • In The News

    Health

    Voting

    Women's Issues

    April 24, 2024
    by Dan McCue
    First Lady Jill Biden Salutes ‘The Power of Research’ at DC Symposium

    WASHINGTON — Even years after the fact, First Lady Dr. Jill Biden recalled the moment with a sense of astonished... Read More

    WASHINGTON — Even years after the fact, First Lady Dr. Jill Biden recalled the moment with a sense of astonished disbelief. Biden was second lady, the wife of Vice President Joe Biden, at the time, and Maria Shriver was the first lady of California.  Both were... Read More

    April 24, 2024
    by Dan McCue
    FDA Approves New Treatment for Urinary Tract Infections

    WASHINGTON — The Food and Drug Administration approved Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated urinary... Read More

    WASHINGTON — The Food and Drug Administration approved Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated urinary tract infections.  “Uncomplicated UTIs are a very common condition impacting women and one of the most frequent reasons for antibiotic use,” said Dr. Peter Kim, M.S.,... Read More

    April 22, 2024
    by Dan McCue
    New Rules Bolster Reproductive Health Care Privacy Under HIPAA

    WASHINGTON — The Biden administration is bolstering existing HIPAA health care privacy rules to provide added protection to women lawfully... Read More

    WASHINGTON — The Biden administration is bolstering existing HIPAA health care privacy rules to provide added protection to women lawfully exercising their right to terminate a pregnancy. The rules will also extend to a woman’s family members and doctors. The Department of Health and Human Services... Read More

    April 22, 2024
    by Dan McCue
    Moderna Suspends Construction on Kenyan Manufacturing Facility

    CAMBRIDGE, Mass. — Moderna said it has paused efforts to build an mRNA manufacturing facility in Kenya due to uncertainty... Read More

    CAMBRIDGE, Mass. — Moderna said it has paused efforts to build an mRNA manufacturing facility in Kenya due to uncertainty over the future demand for COVID-19 vaccines in Africa. According to a statement posted on the drugmaker’s website last week, demand for the vaccines has declined... Read More

    April 9, 2024
    by Dan McCue
    Arizona’s Highest Court Upholds 19th Century Law on Abortion

    PHOENIX — The Arizona Supreme Court held Tuesday that with Roe v. Wade and the federal right to an abortion... Read More

    PHOENIX — The Arizona Supreme Court held Tuesday that with Roe v. Wade and the federal right to an abortion it once recognized now null and void, there’s no reason Arizona can’t enforce a 160-year-old law that bans nearly all abortions. The 4-2 decision upheld a... Read More

    March 26, 2024
    by Tom Ramstack
    Supreme Court Skeptical of Ban on Abortion Pill Mifepristone

    WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access... Read More

    WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access to the abortion pill mifepristone despite objections from anti-abortion activists. The doctors and organizations who sued argued the Food and Drug Administration was wrong in granting... Read More

    News From The Well
    scroll top